CHRWCAUTIOUS

P/E Ratio

37.3x

Updated 297h ago

Sector Performance

77th percentile

CHRW

37.3x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The P/E ratio compares a company's stock price to its earnings per share, and the current 37.3x means investors are paying $37.30 for every $1 of trailing earnings.

This is well above the sector median of 23.9x, placing CHRW in the 79th percentile among its peers — most comparable companies trade at lower multiples. The year-over-year change is not available, but the quarter-over-quarter change shows a +14.0% increase from 32.7x to 37.3x, indicating the stock has become more expensive relative to earnings in the recent period. A high and rising P/E suggests elevated valuation risk, as investors are pricing in strong future growth that may not materialize. This combination of a level above the sector median and an upward trend points to higher downside risk if earnings disappoint. The metric supports the overall CAUTIOUS verdict by confirming the stock trades at a premium with growing valuation pressure.

Frequently Asked Questions

What does the P/E Ratio tell investors about CHRW?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are CHRW's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master CHRW's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CHRW research report

Free account — no credit card

CHRW

37.3x

Sector Median

24.7x

Sector Avg

36.0x

How CHRW's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.